ATP Fund

01Investment Thesis

Early-stage science and engineering ventures solving grand challenges across enhanced health, energy transition and enterprise sustainability, with emphasis on research translation from under-served university ecosystems, supported by the hands-on Proto.n acceleration program.

02Investment Team

KC

Kyle Cox

Managing Partner

BB

Bart Bohn

Partner, ATP Foundation

JS

John Stockton

Venture Partner

BH

Brian Huskinson, PhD

Venture Partner

SM

Safi Modi

Venture Associate

03F4 Research Brief

ATP Fund (ATP Management Company, LLC) is an early-stage deep-tech venture fund based in Austin, Texas. Its tagline is "Powering Science to Save the Planet," and it describes itself as an early-stage venture catalyst that partners with scientific visionaries to solve humanity's grand challenges. The firm's line is that software may be eating the world, but engineering and science are what will save it.

Investment Thesis

The website organizes the thesis into four themes. Exponential Research covers building the future of research-derived companies, with global reach but particular focus on select under-represented ecosystems across the US. Enhanced Health spans behavioral research (the mind), therapeutics and diagnostics (the body), and the practice and delivery of medical treatment. Energy Transition (called Sustainable Energy on the fund page) is about adaptive infrastructure, resiliency and sustainability. Empowered Enterprise covers enterprise sustainability: stakeholder management, workforce shifts from machine learning and AI, and the impact of quantum and distributed-ledger technology on information security. The firm talks about ventures at the intersection of compute and carbon.

A distinctive angle is the research-translation pipeline. ATP argues that US "Freshwater" and Canadian universities receive over $58B of research funding annually yet are underused by traditional venture capital. ATP works with innovators from early research translation onward, with underserved regions and gender-disparity access named as impact targets.

Stage Focus and Check Size

The firm names Pre-seed (Launch), Seed (Nurture) and Series A (Scale) as its emphasis. No check size is published. PitchBook lists the fund's deals without sizes, so check size is left unset rather than guessed. Third-party profiles describe ATP as a seed and early-stage deep tech fund.

Operating Model: Proto.n

ATP's differentiator is Proto.n, its acceleration program, which it calls a time-tested operating model. The partners say they are former founders and focus on four things: Strategy (helping founders prioritize long-term advantages and capital efficiency), Expertise (partners plus an advisor and mentor network), Networks (accelerators, economic development centers and universities across Texas, the US and Canada) and Capital (a network of mission-aligned co-investors who invest alongside the fund). Expect a hands-on, operator-style relationship rather than a passive check.

Funds and Recent Activity

ATP says it has launched its second venture fund. PitchBook lists ATP II as a closed 2023-vintage venture fund managed by ATP Fund in Austin, with 19 investments, the most recent being Deteqt (April 2026, application-specific semiconductors) and QumulusAI (April 2026, business software). Other recent deals PitchBook shows include Marqov (October 2025), Flexergy (May 2025), Diligent Robotics (March 2025), Infleqtion (May 2024), En Solucion (December 2023) and Vera (July 2023). A Form D for "ATP Fund I, a series of ATP AI Ventures, LP" was filed with the SEC on January 6, 2026, suggesting a new vehicle. Fund size is not disclosed in sources reviewed. The firm is plainly still deploying.

Portfolio Highlights

The companies page claims 28 companies, over $320M in cumulative funding, 3 exits (1 IPO, 2 acquisitions) and 2 mergers. Companies named on the page include Toopher (cybersecurity, acquired), Capsenta (data, acquired), Splice, Alafair Biosciences (biomaterials, VersaWrap), SubjectWell, Riskpulse, EYE, OptiEnz Sensors, Diligent (hospital robotics, Moxi), Edoceo (real-time bacteria ID), Between MD (digital mental health for military and PTSD), Parity (AI risk management), GIGA (flare gas to power), Asha Therapeutics (neurological therapeutics) and Elemental Coatings (anti-icing coatings). Press coverage on the site adds Infleqtion (quantum, $11M DoD APFIT award, December 2024) and Everstream Analytics (2024 award). The portfolio is heavily weighted to science-led hardware, biotech, energy and enterprise AI/security.

Team

Kyle Cox is Managing Partner. Bart Bohn is Partner at the ATP Foundation. John Stockton and Brian Huskinson, PhD, are Venture Partners, and Safi Modi is a Venture Associate. The decision process is a small partnership led by the Managing Partner; the exact process is not published.

Founder Preferences and Geography

ATP favors scientist-founders and research spinouts, particularly from university and national-lab ecosystems outside the usual coastal hubs: Texas, the US Midwest and "freshwater" regions, and Canada. Founders should expect a pitch that frames a concrete research-to-commercial path, and the firm explicitly values mission alignment and impact. Lead tendency is not stated; the co-investor network language suggests the fund often syndicates, but this is unconfirmed.

Gaps

Check size, fund size, lead tendency, decision timeline and whether warm intros are required are not published. The website copyright is 2024 and the blog is thin (two posts, late 2024), so PitchBook and press are the best signals for recent activity.

04Selected Portfolio